Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
https://www.businesswire.com/news/home/20210526005542/en/ADC-Therapeutics-Announces-Online-Publication-of-Camidanlumab-Tesirine-Phase-1-Results-in-The-Lancet-Haematology
May 26, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next